Bank of New York Mellon’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.1K Buy
26,991
+16,811
+165% +$57K ﹤0.01% 4210
2026
Q1
$42.6K Buy
+10,180
New +$42.5K ﹤0.01% 4149

Other funds holding SBC

Bank of New York Mellon's SBC Position: Q2 2026 in Review

Bank of New York Mellon increased its SBC Medical Group (SBC) stake by 165% in Q2 2026, buying an estimated $57K and bringing the position to 26,991 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4210.

Bank of New York Mellon first reported a position in SBC in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Bank of New York Mellon held 26,991 shares of SBC Medical Group worth $83.1K as of Q2 2026.
  • Bank of New York Mellon bought 16,811 SBC Medical Group shares in Q2 2026, an estimated $57K.
  • SBC Medical Group made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4210 holding.
  • Bank of New York Mellon first reported a position in SBC Medical Group in Q1 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.